Immunogenicity of a Third Dose of BNT162b2 to Ancestral Severe Acute Respiratory Syndrome Coronavirus 2 and the Omicron Variant in Adults Who Received 2 Doses of Inactivated Vaccine

BACKGROUND: Limited data exist on antibody responses to mixed vaccination strategies that involve inactivated coronavirus disease 2019 (COVID-19) vaccines, particularly in the context of emerging variants. METHODS: We conducted an open-label trial of a third vaccine dose of a messenger RNA (mRNA) va...

Descripción completa

Detalles Bibliográficos
Autores principales: Leung, Nancy H L, Cheng, Samuel M S, Martín-Sánchez, Mario, Au, Niki Y M, Ng, Yvonne Y, Luk, Leo L H, Chan, Karl C K, Li, John K C, Leung, Yonna W Y, Tsang, Leo C H, Chaothai, Sara, Kwan, Kelvin K H, Ip, Dennis K M, Poon, Leo L M, Leung, Gabriel M, Peiris, J S Malik, Cowling, Benjamin J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384189/
https://www.ncbi.nlm.nih.gov/pubmed/35675370
http://dx.doi.org/10.1093/cid/ciac458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384189/
https://www.ncbi.nlm.nih.gov/pubmed/35675370
http://dx.doi.org/10.1093/cid/ciac458

Ejemplares similares